BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22090341)

  • 21. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
    Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
    Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel and nonsentinel lymph node assessment using a combination of one-step nucleic acid amplification and conventional histological examination.
    Jimbo K; Kinoshita T; Suzuki J; Asaga S; Hojo T; Yoshida M; Tsuda H
    Breast; 2013 Dec; 22(6):1194-9. PubMed ID: 24042046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification.
    Alvarenga CA; Paravidino PI; Alvarenga M; Dufloth R; Gomes M; Zeferino LC; Schmitt F
    J Clin Pathol; 2011 Jun; 64(6):493-7. PubMed ID: 21427448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).
    Godey F; Leveque J; Tas P; Gandon G; Poree P; Mesbah H; Lavoue V; Quillien V; Athias CB
    Breast Cancer Res Treat; 2012 Jan; 131(2):509-16. PubMed ID: 21993859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
    Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
    Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [One-step nucleic acid amplification (OSNA) assay for sentinel lymph node metastases as an alternative to conventional postoperative histology in breast cancer: A cost-benefit analysis].
    Guillén-Paredes MP; Carrasco-González L; Cháves-Benito A; Campillo-Soto A; Carrillo A; Aguayo-Albasini JL
    Cir Esp; 2011; 89(7):456-62. PubMed ID: 21664607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
    Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
    Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-step nucleic acid amplification (OSNA): where do we go with it?
    Tamaki Y
    Int J Clin Oncol; 2017 Feb; 22(1):3-10. PubMed ID: 27549784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new diagnostic method for rapid detection of lymph node metastases using a one-step nucleic acid amplification (OSNA) assay in endometrial cancer.
    Nagai T; Niikura H; Okamoto S; Nakabayashi K; Matoda M; Utsunomiya H; Nagase S; Watanabe M; Takeshima N; Yaegashi N
    Ann Surg Oncol; 2015 Mar; 22(3):980-6. PubMed ID: 25190122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
    Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
    Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.
    Piñero-Madrona A; Ruiz-Merino G; Bernet L; Miguel-Martínez B; Vicente-García F; Viguri-Díaz MA; Giménez-Climent J
    Breast; 2014 Dec; 23(6):859-64. PubMed ID: 25283682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer.
    Veys I; Majjaj S; Salgado R; Noterman D; Schobbens JC; Manouach F; Bourgeois P; Nogaret JM; Larsimont D; Durbecq V
    Breast Cancer Res Treat; 2010 Dec; 124(3):599-605. PubMed ID: 19779817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients.
    Vogelaar FJ; Reimers MS; van der Linden RL; van der Linden JC; Smit VT; Lips DJ; van de Velde CJ; Bosscha K
    Ann Surg Oncol; 2014 Nov; 21(12):3924-30. PubMed ID: 24912612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eighteen months clinical experience with the GeneSearch breast lymph node assay.
    Veys I; Durbecq V; Majjaj S; Schobbens JC; Noterman D; Sirtaine N; Martinez MD; Hertens D; Feoli F; Bourgeois P; Nogaret JM; Larsimont D
    Am J Surg; 2009 Aug; 198(2):203-9. PubMed ID: 19249740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-step nucleic acid amplification assay (OSNA) for sentinel lymph node biopsy.
    Tamaki Y
    Breast Cancer; 2015 May; 22(3):230-4. PubMed ID: 22875641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.